IRIS
BABUDIERI, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.550
AS - Asia 7.757
EU - Europa 4.585
SA - Sud America 4.347
AF - Africa 303
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 21
AN - Antartide 1
Totale 29.590
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.251
BR - Brasile 3.902
SG - Singapore 3.228
CN - Cina 2.181
UA - Ucraina 1.285
DE - Germania 755
HK - Hong Kong 735
IT - Italia 604
VN - Vietnam 556
FR - Francia 446
SE - Svezia 435
FI - Finlandia 304
GB - Regno Unito 250
AR - Argentina 140
IN - India 132
TR - Turchia 132
CA - Canada 122
BD - Bangladesh 120
MX - Messico 106
RU - Federazione Russa 103
IQ - Iraq 102
ZA - Sudafrica 88
EC - Ecuador 82
JP - Giappone 63
MA - Marocco 62
CZ - Repubblica Ceca 61
VE - Venezuela 60
UZ - Uzbekistan 56
PK - Pakistan 54
AE - Emirati Arabi Uniti 51
PL - Polonia 51
ES - Italia 47
CO - Colombia 44
BE - Belgio 40
PY - Paraguay 39
NL - Olanda 38
AT - Austria 37
KE - Kenya 37
ID - Indonesia 33
NP - Nepal 29
KR - Corea 27
TN - Tunisia 27
AZ - Azerbaigian 26
AU - Australia 25
JO - Giordania 24
UY - Uruguay 24
PE - Perù 23
RO - Romania 23
LB - Libano 22
CL - Cile 21
DZ - Algeria 21
PH - Filippine 20
SA - Arabia Saudita 20
DO - Repubblica Dominicana 19
IL - Israele 19
KZ - Kazakistan 18
EG - Egitto 17
JM - Giamaica 16
LT - Lituania 16
PS - Palestinian Territory 16
KG - Kirghizistan 15
IR - Iran 14
OM - Oman 14
BG - Bulgaria 12
RS - Serbia 12
AL - Albania 11
EU - Europa 10
HU - Ungheria 9
PA - Panama 9
SN - Senegal 9
BO - Bolivia 8
HN - Honduras 8
KW - Kuwait 8
IE - Irlanda 7
XK - ???statistics.table.value.countryCode.XK??? 7
BY - Bielorussia 6
ET - Etiopia 6
MK - Macedonia 6
MY - Malesia 6
NG - Nigeria 6
AO - Angola 5
BN - Brunei Darussalam 5
CR - Costa Rica 5
NI - Nicaragua 5
QA - Qatar 5
AM - Armenia 4
GE - Georgia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
CI - Costa d'Avorio 3
DK - Danimarca 3
GT - Guatemala 3
GY - Guiana 3
LU - Lussemburgo 3
LY - Libia 3
MD - Moldavia 3
TG - Togo 3
BA - Bosnia-Erzegovina 2
Totale 29.541
Salva come PNG Salva come JPEG
Città #
Dallas 4.072
Singapore 1.743
Chandler 1.432
San Jose 970
Jacksonville 737
Hong Kong 723
Ashburn 596
Princeton 466
Beijing 455
Nanjing 307
New York 300
Dearborn 286
São Paulo 268
Lauterbourg 242
Munich 193
Wilmington 191
Ho Chi Minh City 190
Los Angeles 168
Sassari 158
Shanghai 157
Hanoi 147
Boardman 146
Ann Arbor 130
Rio de Janeiro 129
Nanchang 126
Helsinki 114
Santa Clara 114
Belo Horizonte 102
Shenyang 101
Brasília 86
Woodbridge 81
Tianjin 76
Hebei 66
Changsha 60
Curitiba 58
Tokyo 58
Brno 56
Council Bluffs 56
Porto Alegre 54
Campinas 52
Rome 51
Columbus 49
Nuremberg 49
Guarulhos 48
Orem 47
Frankfurt am Main 46
Salvador 46
Tashkent 46
Warsaw 46
Johannesburg 45
Toronto 44
Denver 42
Goiânia 41
Montreal 41
San Francisco 40
The Dalles 40
Brussels 39
Jiaxing 39
Atlanta 37
Chennai 37
Guangzhou 36
Ningbo 36
Buffalo 35
Cagliari 35
Jinan 35
Zhengzhou 35
Brooklyn 34
Ribeirão Preto 34
Kunming 33
Nairobi 33
London 32
Andover 31
Norwalk 31
Baghdad 30
Chicago 30
Guayaquil 30
São José dos Campos 30
Dhaka 29
Fortaleza 29
Seoul 27
Sorocaba 27
Santo André 26
Stockholm 26
Istanbul 25
Ankara 24
Asunción 24
Baku 24
Hangzhou 23
Izmir 23
Poplar 23
Turku 23
Amman 22
Houston 22
Quito 22
Taizhou 22
Campo Grande 21
Da Nang 21
Florianópolis 21
Joinville 21
Contagem 20
Totale 17.444
Salva come PNG Salva come JPEG
Nome #
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 278
Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study 276
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 263
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 218
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 212
Activation of the potentially neuropathogenic HERV-W/MSRV-type endogenous retroviruses during severe infectious mononucleosis and past Epstein-Barr virus infection: the missing link with multiple sclerosis? 212
A case of vasculitis-like skin eruption associated with COVID-19 204
Anaerobic bacteria and bacterial infections: perspectives on treatment and resistence in Italy 202
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome 201
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 197
Associazione tra Tubercolosi ed infezione da HIV: programma per uno studio multicentrico 193
Blood born viral infections, sexually transmitted diseases and latent tuberculosis in italian prisons: a preliminary report of a large multicenter study 189
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 188
Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area 186
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 181
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 181
Application of a miniaturized system to the study of the intestinal microflora 175
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 174
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 172
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 171
Beta2-microglobulin and Neopterin: predictive markers of AIDS in HIV infection 171
Evaluation of EZH2 expression in hepatitis B patients 170
A young woman with hepatitis after a sore throat 168
An outbreak of Q fever in a prison in Italy 168
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 166
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 165
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 164
A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA 162
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 159
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 159
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 158
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 157
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin 156
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 156
Dental care and HIV-infected individuals: are they equally treated? 156
Association of Tuberculosis risk with the degree of tubercolin reaction in HIV-infected patients 156
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 155
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 151
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 151
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 149
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 149
Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis? 148
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 143
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 141
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 140
Identification of HIV patients with active pulmonary tuberculosis using urine based polymerase chain reaction assay 139
Caratteristiche cliniche e risposta alla terapia anti-HCV nei soggetti HIV-HCV coinfetti con livelli persistentemente normali di ALT 137
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 137
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin 137
Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? 137
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era 135
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 134
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 134
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver. 133
An Outbreak of Q fever in a prison in Italy 133
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution 133
Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration. 132
Travel-Related Typhoid Fever: Narrative Review of the Scientific Literature 131
Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy 130
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 129
Relazione tra antigenemia ed anticorpi nell'evoluzione dell'infezione da HIV 129
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 128
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 128
Tuberculosis Screening before Anti–Hepatitis C Virus Therapy in Prisons 128
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 127
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 127
Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries 126
Produzione di linee cellulari ibride per l'isolamento di virus linfotropi 126
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 125
L'attività di Imipenem contro i microrganismi anaerobi: studio policentrico su ceppi isolati da infezioni umane e confronto in vitro con altri antibiotici 125
Clostridi elicoidali: nuovi patogeni intestinali? Comparazione tra un ceppo umano e ceppi di provenienza animale 123
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. 123
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? 123
Infectious diseases screening approach among refugees: Results from a single-center study 123
High-risk sexual behavior and HIV/STDs cascade of care in migrants: Results from an Italian dedicated outpatient clinic 122
Occurrence of infections during combination treatment with interferons and ribavirin for chronic hepatitis C: Role of neutropenia and of interferon pegylation 122
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy 121
Feasibility and efficacy of eight weeks Glecaprevir/Pibrentasvir to treat incarcerated viremic HCV patients: a case-control study 121
Visceral Leishmaniasis and Pegylated Interferon. Author’s reply 120
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL) 120
Mediterranean spotted fever-like illness in Sardinia, Italy: a clinical and microbiological study 120
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 120
Trasmissione eterosessuale dell'infezione da HIV1 nella provincia di Sassari 120
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 120
Good safety profile and efficacy of leucocyte interferon-alpha in combination with oral ribavirin in treatment-naive patients with chronic hepatitis C: a multicentre, randomised, controlled study 119
Enterococcal infections of the respiratory tract in HIV patients 118
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? 118
Tache Noire in a Patient with Acute Q Fever 118
Safety and efficacy of direct-acting antivirals in transfusion-dependent thalassemic patients with chronic hepatitis C 118
Eritema cronico migrante 118
Flora batterica intestinale ed organismo ospite; aspetti attuali di fisiopatologia 117
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates) 117
HIV related aneurisms 117
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 116
HNK1 perifereal blood lymphocytes in HIV infected patients 116
Diarrea associata a Clostridium spiroforme 115
Characterization of resistance profiles in HCV 2-3-4 DAA-naive and DAA-experienced infected patients in Italy 115
Chronic hepatitis B virus infection in Italy during the twenty-first century: an updated survey in 2019 115
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 115
Directly Observed Therapy to treat HIV Infection in Prisoners 114
Totale 14.835
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.409
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.409
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021440 0 0 0 0 0 0 0 0 0 276 121 43
2021/20221.113 170 14 7 13 10 15 41 79 89 62 134 479
2022/20232.754 278 161 68 455 299 447 23 321 466 29 113 94
2023/2024904 152 60 24 25 238 117 15 42 1 5 64 161
2024/20258.234 131 90 490 200 315 265 748 1.550 2.729 1.122 342 252
2025/202611.693 496 3.087 1.815 1.625 1.171 664 1.700 324 445 366 0 0
Totale 30.121